1. 29976-53-2
2. Ethyl 4-oxopiperidine-1-carboxylate
3. Ethyl 4-oxo-1-piperidinecarboxylate
4. N-carboethoxy-4-piperidone
5. 1-ethoxycarbonyl-4-piperidone
6. 1-carbethoxy-4-piperidone
7. 1-piperidinecarboxylic Acid, 4-oxo-, Ethyl Ester
8. N-ethoxycarbonyl-4-piperidone
9. 4-oxo-1-piperidinecarboxylic Acid Ethyl Ester
10. 1-(ethoxycarbonyl)-4-piperidone
11. Mfcd00006188
12. 1-ethoxycarbonyl-4-piperidinone
13. 1-ethoxycarbonyl-4-oxopiperidine
14. N-ethoxycarbonyl-4-piperidinone
15. 4-oxo-piperidine-1-carboxylic Acid Ethyl Ester
16. 7h5jx1s259
17. Nsc-139022
18. N-carbethoxy-4-piperidon
19. Unii-7h5jx1s259
20. Ethyl 4-oxopiperidinecarboxylate
21. Einecs 249-984-5
22. Loratadine Impurity H
23. 1-carboethoxy-4-piperidone
24. N-carbethoxy-4-piperidinone
25. 1-carbethoxypiperidin-4-one
26. Dsstox_cid_31493
27. Dsstox_rid_97378
28. Dsstox_gsid_57704
29. Schembl158497
30. Dtxsid0057704
31. Ethyl 4-piperidone-n-carboxylate
32. Zinc155166
33. Act02145
34. Bcp23114
35. Hy-y0217
36. Tox21_113793
37. Nsc139022
38. Stl183271
39. Ethyl 4-oxo-piperidine-1-carboxylate
40. Akos000119559
41. Gs-3033
42. Nsc 139022
43. 1-(carboethoxy)-4-piperidinone
44. Ncgc00253669-01
45. Ethyl 4-oxo-1-piperidinecarboxylate, 98%
46. Cas-29976-53-2
47. Db-002178
48. Loratadine Impurity H [ep Impurity]
49. A5543
50. Am20090403
51. Cs-0008473
52. E0403
53. Ft-0607567
54. 4-oxopiperidine-1-carboxylic Acid Ethyl Ester
55. Sr-01000944742
56. Sr-01000944742-1
57. W-106965
58. Q27268281
59. Z33618657
60. F1908-0061
61. Ethyl 4-oxopiperidine-1-carboxylate;ethyl4-oxopiperidine-1-carboxylate
62. Loratadine Impurity H, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 171.19 g/mol |
---|---|
Molecular Formula | C8H13NO3 |
XLogP3 | -0.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 171.08954328 g/mol |
Monoisotopic Mass | 171.08954328 g/mol |
Topological Polar Surface Area | 46.6 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 181 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
CAS Number : 29976-53-2
End Use API :
End Use API : Domperidone, Haloperidol
About the Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domestic & international markets...
CAS Number : 29976-53-2
End Use API :
End Use API : Loratadine, Sufentanil Citrate, Tedatioxetine Hydrobromide
About the Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-growth...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
Tofigh Daru develops & synthesizes a diverse range of APIs in Anticancer, Narcotics, Cardiovascular to Immunomodulatory Segments.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.
Parand Darou is a knowledge-based company, focused on the production of Narcotic APIs.
LOOKING FOR A SUPPLIER?